Literature DB >> 11604470

Rapamycin's resurrection: a new way to target the cancer cell cycle.

K Garber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11604470     DOI： 10.1093/jnci/93.20.1517

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  25 in total

1.  Design of aging intervention studies: the NIA interventions testing program.

Authors:  N L Nadon; R Strong; R A Miller; J Nelson; M Javors; Z D Sharp; J M Peralba; D E Harrison
Journal:  Age (Dordr)       Date:  2008-04-18

Review 2.  Rapalogs in cancer prevention: anti-aging or anticancer?

Authors:  Mikhail V Blagosklonny
Journal:  Cancer Biol Ther       Date:  2012-11-14       Impact factor: 4.742

3.  Multi-algorithm and multi-model based drug target prediction and web server.

Authors:  Ying-tao Liu; Yi Li; Zi-fu Huang; Zhi-jian Xu; Zhuo Yang; Zhu-xi Chen; Kai-xian Chen; Ji-ye Shi; Wei-liang Zhu
Journal:  Acta Pharmacol Sin       Date:  2014-02-03       Impact factor: 6.150

4.  A novel rapamycin-polymer conjugate based on a new poly(ethylene glycol) multiblock copolymer.

Authors:  Wanyi Tai; Zhijin Chen; Ashutosh Barve; Zhonghua Peng; Kun Cheng
Journal:  Pharm Res       Date:  2013-09-26       Impact factor: 4.200

5.  Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips.

Authors:  Jing Huang; Heng Zhu; Stephen J Haggarty; David R Spring; Heejun Hwang; Fulai Jin; Michael Snyder; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-11       Impact factor: 11.205

6.  Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.

Authors:  Valerie I Brown; Junjie Fang; Keith Alcorn; Rosalind Barr; Jenny M Kim; Robert Wasserman; Stephan A Grupp
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  Rapamycin inhibits GM-CSF-induced neutrophil migration.

Authors:  Julian Gomez-Cambronero
Journal:  FEBS Lett       Date:  2003-08-28       Impact factor: 4.124

8.  Rapamycin extends murine lifespan but has limited effects on aging.

Authors:  Frauke Neff; Diana Flores-Dominguez; Devon P Ryan; Marion Horsch; Susanne Schröder; Thure Adler; Luciana Caminha Afonso; Juan Antonio Aguilar-Pimentel; Lore Becker; Lillian Garrett; Wolfgang Hans; Moritz M Hettich; Richard Holtmeier; Sabine M Hölter; Kristin Moreth; Cornelia Prehn; Oliver Puk; Ildikó Rácz; Birgit Rathkolb; Jan Rozman; Beatrix Naton; Rainer Ordemann; Jerzy Adamski; Johannes Beckers; Raffi Bekeredjian; Dirk H Busch; Gerhard Ehninger; Jochen Graw; Heinz Höfler; Martin Klingenspor; Thomas Klopstock; Markus Ollert; Jörg Stypmann; Eckhard Wolf; Wolfgang Wurst; Andreas Zimmer; Helmut Fuchs; Valérie Gailus-Durner; Martin Hrabe de Angelis; Dan Ehninger
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

9.  TOR controls transcriptional and translational programs via Sap-Sit4 protein phosphatase signaling effectors.

Authors:  John R Rohde; Susan Campbell; Sara A Zurita-Martinez; N Shane Cutler; Mark Ashe; Maria E Cardenas
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

10.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.

Authors:  David E Harrison; Randy Strong; Zelton Dave Sharp; James F Nelson; Clinton M Astle; Kevin Flurkey; Nancy L Nadon; J Erby Wilkinson; Krystyna Frenkel; Christy S Carter; Marco Pahor; Martin A Javors; Elizabeth Fernandez; Richard A Miller
Journal:  Nature       Date:  2009-07-08       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.